SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer
Acta Oncologica · 04.05.2026 · 65 · 375-378
DOI: 10.2340/ao.v65.45126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Oncologica, online erschienen am 04.05.2026. Verfasst von Karin Welén und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. karin.welen@gu.se. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
study-specific procedures. Consent includes bio-marker profiling of routine tissue samples and optional biobanking of blood and urine. Participants agree to the use of all clinical and research data for trial eligibility matching and centralized invitations. After inclusion, they may have no further contact or be invited to additional studies or trials requiring separate consent.
Autor:innen und Institutionen
- Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. karin.welen@gu.se.
- Department of Diagnostics and Intervention, Umeå University, Sweden. andreas.josefsson@umu.se.
ORCID-Profile: Karin Welén, Andreas Josefsson
Zitieren
APA
Welén, K., Josefsson, A., & SPRINTR study group (2026). SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer. Acta Oncologica, 65, 375-378. https://doi.org/10.2340/ao.v65.45126
Vancouver
Welén K, Josefsson A, SPRINTR study group. SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer. Acta Oncologica. 2026;65:375-378. doi:10.2340/ao.v65.45126
BibTeX
@article{Weln2026,
author = {Welén, Karin and Josefsson, Andreas and SPRINTR study group, SPRINTR study group},
title = {SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer},
journal = {Acta Oncologica},
year = {2026},
volume = {65},
pages = {375--378},
doi = {10.2340/ao.v65.45126}
}
EUVIMED